Serum-free production and column purification of adeno-associated virus type 5

Journal of Virological Methods

Volumn 114, Issue 2, 2003, Pages 115-124

  Smith, Richard H ^a   Ding, Chuantian ^a   Kotin, Robert M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

AAV; AAV 5; Adeno associated virus

Indexed keywords

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS TYPE 5; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; GEL FILTRATION CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; SOLVENT EXTRACTION; VIRUS PARTICLE;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2;

EID: 0242643501     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2003.09.002     Document Type: Article

References (23)

1. Auricchio A., Hildinger M., O'Connor E., Gao G.-P., Wilson J.M. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12:2001a;71-76.
2. Auricchio A., O'Connor E., Hildinger M., Wilson J.M. A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors. Mol. Ther. 4:2001b;372-374.
3. Bantel-Schaal U., zur Hausen H. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology. 134:1984;52-63.
4. Brument N., Morenweiser R., Blouin V., Toublanc E., Raimbaud I., Cherel Y., Folliot S., Gaden F., Boulanger P., Kroner-Lux G., Moullier P., Rolling F., Salvetti A. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5. Mol. Ther. 6:2002;678-686.
5. Chiorini J.A., Yang L., Liu Y., Safer B., Kotin R.M. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol. 71:1997;6823-6833.
6. Chiorini J.A., Kim F., Yang L., Kotin R.M. Cloning and characterization of adeno-associated virus type 5. J. Virol. 73:1999;1309-1319.
7. Clark K.R., Liu X., McGrath J.P., Johnson P.R. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10:1999;1031-1039.
8. Davidson B.L., Stein C.S., Heth J.A., Martins I., Kotin R.M., Derksen T.A., Zabner J., Ghodsi A., Chiorini J.A. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3428-3432.
9. Duan D., Yan Z., Yue Y., Ding W., Engelhardt J.F. Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75:2001;7662-7671.
10. Gao G.-P., Alvira M.R., Wang L., Calcedo R., Johnston J., Wilson J.M. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99:2002;11854-11859.
11. Georg-Fries B., Biederlack S., Wolf J., zur Hausen H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology. 134:1984;64-71.
12. Hoggan M.D., Blacklow N.R., Rowe W.P. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. U.S.A. 55:1966;1467-1474.
13. Kaludov N., Handelman B., Chiorini J.A. Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum. Gene Ther. 13:2002;1235-1243.
14. Mayor H.D., Drake S., Stahmann J., Mumford D.M. Antibodies to adeno-associated virus satellite virus and herpes simplex in sera from cancer patients and normal adults. Am. J. Obstet. Gynecol. 126:1976;100-104.
15. Parks W.P., Melnick J.L., Rongey R., Mayor H.D. Physical assay and growth cycle studies of a defective adeno-satellite virus. J. Virol. 1:1967;171-180.
16. Rabinowitz J.E., Rolling F., Li C., Conrath H., Xiao W., Xiao X., Samulski R.J. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76:2002;791-801.
17. Rutledge E.A., Halbert C.L., Russell D.W. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Virol. 72:1998;309-319.
18. Smith R.H., Afione S.A., Kotin R.M. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid. Biotechniques. 33:2002;204-211.
19. Summerford C., Samulski R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1998;1438-1445.
20. Walters R.W., Yi S.M.P., Keshavjee S., Brown K.E., Welsh M.J., Chiorini J.A., Zabner J. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276:2001;20610-20616.
21. Zabner J., Seiler M., Walters R., Kotin R.M., Fulgeras W., Davidson B.L., Chiorini J.A. Adeno-associated virus type 5 (AAV-5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74:2000;3852-3858.
22. Zolotukhin S., Byrne B.J., Mason E., Zolotukhin I., Potter M., Chesnut K., Summerford C., Samulski R.J., Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:1999;973-985.
23. Zolotukhin S., Potter M., Zolotukhin I., Sakai Y., Loiler S., Fraites T.J. Jr., Chiodo V.A., Phillipsberg T., Muzyczka N., Hauswirth W.W., Flotte T.R., Byrne B.J., Snyder R.O. Production and purification of serotypes 1, 2, and 5 recombinant adeno-associated viral vectors. Methods. 28:2002;158-167.